Novartis Institutes for BioMedical Research, Inc. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Novartis Institutes for BioMedical Research, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Novartis Institutes for BioMedical Research, Inc.. Novartis Institutes for BioMedical Research, Inc. is a 10% Owner in Intellia Therapeutics, Inc. ($NTLA) and a 10% Owner in Surface Oncology, Inc. ($SURF).
Address: 250 MASSACHUSETTS AVENUE CAMBRIDGE 02139 MA
Companies in which Novartis Institutes for BioMedical Research, Inc. is an Insider
Intellia Therapeutics, Inc.
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of Novartis Institutes for BioMedical Research, Inc.: 10% Owner
Holdings: 4,129,903 shares
Current Value: $54,927,710
Latest Transaction: Dec 14 2017
$NTLA Market Capitalization: $471.17M
$NTLA Previous Close: $13.30
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Surface Oncology, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Novartis Institutes for BioMedical Research, Inc.: 10% Owner
Holdings: 2,272,726 shares
Latest Transaction: Apr 23 2018
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Novartis Institutes for BioMedical Research, Inc.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 23 2018 | SURF | Surface Oncology, ... | Novartis Institutes for BioMed ... | 10% Owner | Option Exercise | C | 0.00 | 5,214,286 | 0 | 0 | |
| Apr 23 2018 | SURF | Surface Oncology, ... | Novartis Institutes for BioMed ... | 10% Owner | Option Exercise | C | 0.00 | 1,571,429 | 0 | 0 | |
| Apr 23 2018 | SURF | Surface Oncology, ... | Novartis Institutes for BioMed ... | 10% Owner | Buy | P | 15.00 | 766,666 | 11,499,990 | 3,948,482 | 3.2 M to 3.9 M (+24.10 %) |
| Apr 23 2018 | SURF | Surface Oncology, ... | Novartis Institutes for BioMed ... | 10% Owner | Buy | C | 0.00 | 909,090 | 0 | 3,181,816 | 2.3 M to 3.2 M (+40.00 %) |
| Apr 23 2018 | SURF | Surface Oncology, ... | Novartis Institutes for BioMed ... | 10% Owner | Buy | C | 0.00 | 2,272,726 | 0 | 2,272,726 | 0 to 2.3 M |
| Apr 23 2018 | SURF | Surface Oncology, ... | Novartis Institutes for BioMed ... | 10% Owner | Option Exercise | C | 0.00 | 5,214,286 | 0 | 0 | |
| Apr 23 2018 | SURF | Surface Oncology, ... | Novartis Institutes for BioMed ... | 10% Owner | Option Exercise | C | 0.00 | 1,571,429 | 0 | 0 |
View all Novartis Institutes for BioMedical Research, Inc. insider transactions.